ArticleMolecular and cellular biochemistry2026
Benzo[a]pyrene-derived quinones exploit mitochondrial electron transport to drive catalytic redox cycling and potent ROS amplification.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benzo[a]pyrene (BP)-derived quinones are major oxidative metabolites of this ubiquitous environmental carcinogen, yet the mechanisms by which they generate reactive oxygen species (ROS) remain poorly understood. Here, we tested the hypothesis that BP-derived quinones exploit mitochondrial electron transport to undergo redox cycling and amplify ROS production. Using isolated mitochondria energized with either pyruvate/malate or succinate, we found that BP-1,6-quinone (BP-1,6-Q), BP-3,6-quinone (BP-3,6-Q), BP-6,12-quinone (BP-6,12-Q), and BP-7,8-quinone (BP-7,8-Q) stimulated potassium cyanide-resistant oxygen consumption, indicating active mitochondrial redox cycling. BP quinone redox cycling was accompanied by substantial production of superoxide and hydrogen peroxide, with BP-1,6-Q, BP-3,6-Q, and BP-6,12-Q exhibiting the greatest activity. Notably, BP-1,6-Q induced robust ROS generation at submicromolar concentrations, suggesting that mitochondria can serve as highly efficient amplifiers of BP quinone-mediated oxidative stress. Pharmacological dissection of the mitochondrial electron transport chain suggested complexes I and III as the principal sites supporting BP quinone redox cycling and ROS production, whereas the contributions of complexes II and IV were negligible. These findings indicate that BP-derived quinones exploit electron flow through mitochondrial complexes I and III to drive catalytic redox cycling and potent ROS amplification. This previously underappreciated mechanism provides a mechanistic link between BP metabolism, mitochondrial oxidative stress, and the pathogenesis of BP-associated toxicity.
Indexed as
Identifiers
42742852What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.